Mark Schofield, PhD, is senior R&D manager, Pall Life Sciences.
Assessing Viral Inactivation for Continuous Processing
Testing demonstrates an automated semi-continuous process strategy for viral inactivation with steps that mimic batch processing.
Going from Fed-Batch to Perfusion
Perfusion processes can attractive for biologics drug manufacturing; however, obstacles remain.
Platform for Integrated Continuous Bioprocessing
Continuous processing of 100 g of monoclonal antibody in 24 hours has been demonstrated using lab-scale equipment.